| Previous close | 1.6700 |
| Open | 1.8400 |
| Bid | 1.8400 |
| Ask | 1.8700 |
| Strike | 28.00 |
| Expiry date | 2024-10-18 |
| Day's range | 1.8000 - 1.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.88k |
Barrons.comPfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
ZacksInvestors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comBioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.
© 2024 Yahoo. All rights reserved.